Stefan Linehan Promoted to Vice President of Operations and Development at TissueVision, Inc.

Stefan Linehan Promoted to Vice President of Operations and Development at TissueVision, Inc.




Stefan Linehan Promoted to Vice President of Operations and Development at TissueVision, Inc.

New role will expand TissueVision’s imaging and research services business

NEWTON, Mass.–(BUSINESS WIRE)–TissueVision, Inc., a leading provider of life sciences imaging solutions, announced today the promotion of Stefan Linehan to Vice President of Operations and Development. In his new role, Linehan will expand TissueVision’s service offerings through strategic partnerships with clients and industry organizations. He will continue to oversee sales and growth of TissueVision’s Serial Two-Photon Plus (STP2) imaging and solutions platform.

With over twenty years of experience in Good Laboratory Practices contract research services, Linehan is an expert on ex vivo imaging techniques, including cryo-imaging techniques such as autoradiography and imaging mass spectrometry. Linehan has pushed the technical boundaries of merging multiple imaging modalities. Researchers use multi-modal data presented in a 3D environment to understand the molecular distribution and heterogeneity of tissues.

“Stefan is a superb member of our team. Through his leadership, our expansion into imaging services has been exceptional and far-reaching,” said Tim Ragan, Ph.D., Founder and CEO of TissueVision. “Our novel approach integrates numerous secondary analysis datasets into a STP2 3D scaffolding and gives researchers the high-resolution imaging they need to study spatial biology with confidence.”

Previously, Linehan oversaw mass spectrometry imaging (MSI) services as Director of North America and Head of Japan at ImaBiotech. Linehan has also held leadership positions at Invicro, XenoBiotic Laboratories, WIL Research Laboratories, and Wyeth Pharmaceuticals.

About TissueVision, Inc.

TissueVision, Inc., provides 3D tissue imaging and analysis solutions for the research market. The company’s STP2 platform creates high-resolution 3D models that deliver actionable results. TissueVision operates out of a new 10,500 square foot life sciences research facility and offers project design, documentation based on Good Laboratory Practices, and quality control review measures to researchers in a range of therapeutic areas, including neuroscience, cancer, dermatology, and more.

www.tissuevision.com

Contacts

Hannah Clifford
info@tissuevision.com